Abstract:Head and neck squamous cell carcinoma (HNSCC) is currently one of the most common malignancies with a poor prognosis worldwide. Meanwhile, small ubiquitin‐like modifier (SUMO) specific peptidase 1 (SENP1) was associated with ferroptosis. However, the specific functions and underlying mechanisms of action of SENP1 in ferroptosis and tumor progression of HNSCC remain to be established. The findings of the present study implicated a novel ferroptosis pathway in the initiation and progression of HNSCC, providing new functional targets to guide future therapy. In the present study, The Cancer Genome Atlas database was employed to establish a gene model related to ferroptosis and verified SENP1 as a key gene via transcriptome sequencing. Expression of SENP1 in HNSCC tissue and CAL‐27 cells was detected based on reverse transcription‐quantitative PCR and western blot analysis. Proliferation and migration abilities of cells were determined using Cell Counting Kit‐8, wound healing and Transwell experiments. Expression levels of iron, glutathione (GSH) and lipid peroxidation end‐product malondialdehyde (MDA) under conditions of silencing of SENP1 with shRNA lentivirus were assayed. Additionally, the relationship between SENP1 and long‐chain acyl‐coenzyme A synthase 4 (ACSL4) was validated with the aid of immunoblotting and co‐immunoprecipitation (co‐IP). Finally, the influence of shSENP1 on the expression of key ferroptosis proteins, glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11, was evaluated via western blotting. It was revealed that SENP1 was significantly overexpressed in HNSCC and associated with low patient survival. Silencing of SENP1 led to significant suppression of cell proliferation, migration and invasion, increase in the contents of iron ions and MDA and decline in GSH levels in HNSCC cells, thereby enhancing ferroptosis and inhibiting disease progression. Conversely, overexpression of SENP1 suppressed ferroptosis and promoted progression of HNSCC. Co‐IP and western blot analyses revealed a SUMOylation link between SENP1 and ACSL4. SENP1 reduced the stability of ACSL4 protein through deSUMOylation, leading to inhibition of ferroptosis. SENP1 silencing further inhibited the expression of the key iron death protein, GPX4, to regulate ferroptosis. Taken together, SENP1 deficiency promoted ferroptosis and inhibited tumor progression through reduction of SUMOylation of ACSL4 in HNSCC. The collective results of the present study supported the utility of SENP1 as an effective predictive biomarker for targeted treatment of HNSCC.

SENP2-NDR2-p21 Axis Modulates Lung Cancer Cell Growth

Interplay Of Mkp-1 And Nrf2 Drives Tumor Growth And Drug Resistance In Non-Small Cell Lung Cancer

The USP21/YY1/SNHG16 Axis Contributes to Tumor Proliferation, Migration, and Invasion of Non-Small-cell Lung Cancer

SUMO-specific Protease 1 Regulates the in Vitro and in Vivo Growth of Colon Cancer Cells with the Upregulated Expression of CDK Inhibitors.

Over-expression of Small Ubiquitin-Like Modifier Proteases 1 Predicts Chemo-Sensitivity and Poor Survival in Non-Small Cell Lung Cancer.

SENP2 Regulates Hepatocellular Carcinoma Cell Growth by Modulating the Stability of Β-Catenin

SENP1 inhibition suppresses the growth of lung cancer cells through activation of A20-mediated ferroptosis

Panax Notoginseng Saponins Attenuate Lung Cancer Growth in Part Through Modulating the Level of Met/miR-222 Axis.

The Anti-Lung Cancer Activity of SEP is Mediated by the Activation and Cytotoxicity of NK Cells Via TLR2/4 in Vivo.

Sumo-regulatory SENP2 controls the homeostatic squamous mitosis-differentiation checkpoint

Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression

Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition

Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor

Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation Nsenl Reverses Cisplatin Resistance in Lung Cancer Xenografts

SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1

Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathway

Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer

SIRT2 Inhibits Non-Small Cell Lung Cancer Cell Growth Through Impairing Skp2-mediated P27 Degradation

The Clinical Significance and Potential Molecular Mechanisms of Synaptojanin 2 in Lung Adenocarcinoma

Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D

LncRNA SNHG3 Promotes Proliferation and Metastasis of Non-Small-Cell Lung Cancer Cells Through miR-515-5p/SUMO2 Axis